The placenta in preeclampsia.

The root cause of preeclampsia is the placenta. Preeclampsia begins to abate with the delivery of the placenta and can occur in the absence of a fetus but with the presence of trophoblast tissue with hydatidiform moles. In view of this, study of the placenta should provide insight into the pathophysiology of preeclampsia. In this presentation we examine placental pathological and pathophysiological changes with preeclampsia and fetal growth restriction (FGR). It would seem that this comparison should be illuminating as both conditions are associated with similarly abnormal placentation yet only in preeclampsia is there a maternal pathophysiological syndrome. Similar insights about early and late onset preeclampsia should also be provided by such information.We report that the placental abnormalities in preeclampsia are what would be predicted in a setting of reduced perfusion and oxidative stress. However, the differences from FGR are inconsistent. The most striking differences between the two conditions are found in areas that have been the least studied. There are differences between the placental findings in early and late onset preeclampsia but whether these are qualitative, indicating different diseases, or simply quantitative differences within the same disease is difficult to determine.We attempt to decipher the true differences, seek an explanation for the disparate results and provide recommendations that we hope may help resolve these issues in future studies.

[1]  F. Lyall.  The human placental bed revisited. , 2002, Placenta.

[2]  M. Ueno,et al.  Hypoxia‐inducible factor‐2α is involved in enhanced apoptosis in the placenta from pregnancies with fetal growth restriction , 2004 .

[3]  A. W. Woods,et al.  Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy , 2009, Placenta.

[4]  B. Huppertz.  Placental Origins of Preeclampsia: Challenging the Current Hypothesis , 2008, Hypertension.

[5]  F. Assche,et al.  Immunohistochemical Identification of Placental Bed Biopsies and the Implications for the Inclusion of Specimens when Studying the Spiral Artery Response to Pregnancy , 1994 .

[6]  W. Choi,et al.  Proteomic Analysis Reveals an Elevated Expression of Heat Shock Protein 27 in Preeclamptic Placentas , 2011, Gynecologic and Obstetric Investigation.

[7]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[8]  J. Weinstein.  'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. , 2002, Current opinion in pharmacology.

[9]  T. Nikaido,et al.  Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction , 2004, Virchows Archiv.

[10]  F. Lyall,et al.  Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. , 2001, American journal of obstetrics and gynecology.

[11]  R. Romero,et al.  The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. , 2011, American journal of obstetrics and gynecology.

[12]  B. Sibai,et al.  The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. , 2003, American journal of obstetrics and gynecology.

[13]  M. Trotter,et al.  Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells , 2011, Placenta.

[14]  S. Drăghici,et al.  Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[15]  R. Ness,et al.  Placental HIF-1α, HIF-2α, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction , 2007 .

[16]  J. Shin,et al.  Cytokine-related genes and oxidation-related genes detected in preeclamptic placentas , 2010, Archives of Gynecology and Obstetrics.

[17]  M. Klebanoff,et al.  Prediction of Adverse Outcomes by Common Definitions of Hypertension in Pregnancy , 2001, Obstetrics and gynecology.

[18]  Qi Chen,et al.  The role of autocrine TGFβ1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre‐eclampsia , 2010, The Journal of pathology.

[19]  Peilin Zhang,et al.  Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation. , 2006, American journal of obstetrics and gynecology.

[20]  I. Sargent,et al.  Changes in Microparticle Numbers and Cellular Origin During Pregnancy and Preeclampsia , 2008, Hypertension in pregnancy.

[21]  S. Shim,et al.  Preeclampsia leads to dysregulation of various signaling pathways in placenta , 2011, Journal of hypertension.

[22]  W. B. Robertson,et al.  The role of the spiral arteries in the pathogenesis of preeclampsia. , 1972, Obstetrics and gynecology annual.

[23]  G. Acharya,et al.  Differential placental gene expression in severe preeclampsia. , 2009, Placenta.

[24]  G. Saade,et al.  Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. , 2008, American journal of obstetrics and gynecology.

[25]  I. Sargent,et al.  Systemic Inflammatory Priming in Normal Pregnancy and Preeclampsia: The Role of Circulating Syncytiotrophoblast Microparticles1 , 2007, The Journal of Immunology.

[26]  W. B. Robertson,et al.  The pathological response of the vessels of the placental bed to hypertensive pregnancy. , 1967, The Journal of pathology and bacteriology.

[27]  R. Pijnenborg,et al.  Renin-like immunoreactivity in uterus and placenta from normotensive and hypertensive pregnancies. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[28]  C. Hubel,et al.  Increased Myeloperoxidase in the Placenta and Circulation of Women With Preeclampsia , 2008, Hypertension.

[29]  Increased Plasma Adenosine Concentrations and the Severity of Preeclampsia , 2002, Obstetrics and gynecology.

[30]  M. Beckmann,et al.  Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. , 2007, Clinical science.

[31]  L. Hunt,et al.  Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. , 2009, American journal of obstetrics and gynecology.

[32]  E. Podjarny,et al.  Animal models of preeclampsia. , 1999, Seminars in perinatology.

[33]  J. Kingdom,et al.  Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. , 2003, Placenta.

[34]  I. Crocker,et al.  An Image Analysis Technique for the Investigation of Variations in Placental Morphology in Pregnancies Complicated by Preeclampsia With and Without Interauterine Growth Restriction , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[35]  C. Wingren,et al.  Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays , 2010, Proteomics. Clinical applications.

[36]  P. Baker,et al.  Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. , 2003, Placenta.

[37]  P. Sibbons,et al.  Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta? , 2006, Placenta.

[38]  J. Roberts,et al.  Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. , 2009, Placenta.

[39]  P. Gibson,et al.  Maternal asthma is associated with reduced female fetal growth. , 2003, American journal of respiratory and critical care medicine.

[40]  M. Beckmann,et al.  Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre‐eclampsia and intrauterine growth restriction , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[41]  Robertson Wb,et al.  The role of the spiral arteries in the pathogenesis of pre-eclampsia. , 1970 .

[42]  E. Johnstone,et al.  Differential proteomic analysis of highly purified placental cytotrophoblasts in pre‐eclampsia demonstrates a state of increased oxidative stress and reduced cytotrophoblast antioxidant defense , 2011, Proteomics.

[43]  D. Charnock-Jones,et al.  Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia , 2009, Placenta.

[44]  I. Papassotiriou,et al.  Circulating Levels of Inflammatory Markers in Intrauterine Growth Restriction , 2010, Mediators of inflammation.

[45]  Jim Roberts.  Pre-eclampsia: Pre-eclampsia a two-stage disorder: what is the linkage? Are there directed fetal/placental signals? , 2007 .

[46]  T. Mayhew,et al.  A stereological perspective on placental morphology in normal and complicated pregnancies , 2009, Journal of anatomy.

[47]  P. Casanello,et al.  Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. , 2008, Placenta.

[48]  C. Damsky,et al.  Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia. , 1998, Journal of reproductive immunology.

[49]  V. Clifton,et al.  Maternal asthma as a model for examining fetal sex-specific effects on maternal physiology and placental mechanisms that regulate human fetal growth. , 2004, Placenta.

[50]  L. Magee,et al.  Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. , 2006, Placenta.

[51]  P. Stone,et al.  Spreading endothelial cell dysfunction in response to necrotic trophoblasts. Soluble factors released from endothelial cells that have phagocytosed necrotic shed trophoblasts reduce the proliferation of additional endothelial cells. , 2010, Placenta.

[52]  R. Pijnenborg,et al.  The uterine spiral arteries in human pregnancy: facts and controversies. , 2006, Placenta.

[53]  E. Gratacós,et al.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[54]  H. Stepan,et al.  Reduced antioxidant capacity in second‐trimester pregnancies with pathological uterine perfusion , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[55]  I. Mendilcioglu,et al.  Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia. , 2011, Clinical and experimental obstetrics & gynecology.

[56]  R. Andriantsitohaina,et al.  Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. , 2006, The American journal of pathology.

[57]  J. Gabert,et al.  Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth Restriction , 2009, Fetal Diagnosis and Therapy.

[58]  James M. Roberts,et al.  Contemporary concepts of the pathogenesis and management of preeclampsia. , 2002, JAMA.

[59]  F. Arias,et al.  Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. , 1993, American journal of obstetrics and gynecology.

[60]  G. Burton,et al.  Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta. , 2009, Taiwanese journal of obstetrics & gynecology.

[61]  I. Crocker,et al.  Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. , 2007, Placenta.

[62]  B Huppertz,et al.  Development of the placental villous tree and its consequences for fetal growth. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[63]  I. Crocker,et al.  Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast , 2011, Apoptosis.

[64]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[65]  J. Elema,et al.  MORPHOLOGICAL CHANGES OF THE SPIRAL ARTERIES IN THE PLACENTAE BED IN RELATION TO PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATION , 1981, British journal of obstetrics and gynaecology.

[66]  R. K. Miller,et al.  Continuous measurement of ATP by 31P-NMR in term human dually perfused placenta in vitro: response to ischemia. , 1995, Journal of applied physiology.

[67]  J. Roberts,et al.  Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.

[68]  M. Egbor,et al.  Maternal medicine: Morphometric placental villous and vascular abnormalities in early‐ and late‐onset pre‐eclampsia with and without fetal growth restriction , 2006 .

[69]  J. Kitzmiller,et al.  Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies. , 1981, American journal of obstetrics and gynecology.

[70]  James Lyons-Weiler,et al.  Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. , 2009, Placenta.

[71]  M. Permezel,et al.  Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants. , 2011, American journal of obstetrics and gynecology.

[72]  T. Khong,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .

[73]  James M. Roberts,et al.  Pregnancy-Related Hypertension , 2009 .

[74]  T. Okai,et al.  Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre‐eclampsia later in pregnancy: implications for screening , 2011, Prenatal diagnosis.

[75]  L. Vatten,et al.  Placenta weight in pre‐eclampsia , 2008, Acta obstetricia et gynecologica Scandinavica.

[76]  W. B. Robertson,et al.  Placental bed vessels. , 1973, American journal of obstetrics and gynecology.

[77]  D. Charnock-Jones,et al.  The influence of the intrauterine environment on human placental development. , 2010, The International journal of developmental biology.

[78]  I. Sargent,et al.  Placental stress and pre-eclampsia: a revised view. , 2009, Placenta.

[79]  R. Pijnenborg,et al.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies , 1994, British journal of obstetrics and gynaecology.

[80]  J. Kingdom,et al.  Oxygen and placental villous development: origins of fetal hypoxia. , 1997, Placenta.

[81]  L. Magee,et al.  Subclassification of Preeclampsia , 2003, Hypertension in pregnancy.

[82]  I. Sargent,et al.  Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. , 2003, Journal of reproductive immunology.

[83]  D. Roberts,et al.  The placenta in pre-eclampsia and intrauterine growth restriction , 2008, Journal of Clinical Pathology.

[84]  J. Eriksson,et al.  In preeclampsia, the placenta grows slowly along its minor axis. , 2010, The International journal of developmental biology.

[85]  V. Clifton.  Sexually dimorphic effects of maternal asthma during pregnancy on placental glucocorticoid metabolism and fetal growth , 2005, Cell and Tissue Research.

[86]  T M Mayhew,et al.  The placenta in pre-eclampsia and intrauterine growth restriction: studies on exchange surface areas, diffusion distances and villous membrane diffusive conductances. , 2007, Placenta.

[87]  H. Kurahashi,et al.  Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. , 2007, Placenta.

[88]  M. Naki,et al.  The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies , 2005, Archives of Gynecology and Obstetrics.

[89]  V. Sapin,et al.  Hypoxia-activated genes from early placenta are elevated in Preeclampsia, but not in Intra-Uterine Growth Retardation , 2005, BMC Genomics.

[90]  I. Sargent,et al.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles , 2007, The Journal of Immunology.

[91]  B. Gharesi-Fard,et al.  Proteome differences of placenta between pre-eclampsia and normal pregnancy. , 2010, Placenta.

[92]  T. Okai,et al.  Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. , 2004, Clinical chemistry.

[93]  T. Okai,et al.  Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. , 2003, American journal of obstetrics and gynecology.

[94]  L. Vatten,et al.  Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. , 2011, American Journal of Epidemiology.

[95]  I. Sargent,et al.  The effect of placental syncytiotrophoblast microvillous membranes from normal and pre‐eclamptic women on the growth of endothelial cells in vitro , 1993, British journal of obstetrics and gynaecology.

[96]  I. Sargent,et al.  The functions of microparticles in pre-eclampsia. , 2011, Seminars in thrombosis and hemostasis.

[97]  C. Rodeck,et al.  Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[98]  R. Romero,et al.  Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. , 2007, Nutrition reviews.

[99]  J. Bonnar,et al.  AN ULTRASTRUCTURAL STUDY OF UTERO‐PLACENTAL SPIRAL ARTERIES IN HYPERTENSIVE AND NORMOTENSIVE PREGNANCY AND FETAL GROWTH RETARDATION , 1981 .

[100]  B. Psaty,et al.  Differential placental gene expression in preeclampsia , 2008, American journal of obstetrics and gynecology.

[101]  Jing Xu,et al.  Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. , 2008, The Journal of clinical endocrinology and metabolism.

[102]  N. D'Ambrosi,et al.  Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters , 2009, The FEBS journal.

[103]  C. Hubel,et al.  The two stage model of preeclampsia: variations on the theme. , 2009, Placenta.

[104]  B. Sibai,et al.  Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. , 2001, American journal of obstetrics and gynecology.

[105]  James M. Roberts,et al.  Preeclampsia: recent insights. , 2005, Hypertension.

[106]  L. Weissfeld,et al.  Selective Overexpression of the Hypoxia-Inducible Transcription Factor, HIF-2α, in Placentas from Women with Preeclampsia , 2001 .

[107]  R. Ness,et al.  Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. , 2005, The Journal of clinical endocrinology and metabolism.

[108]  L. Myatt,et al.  Oxidative stress in the placenta , 2004, Histochemistry and Cell Biology.

[109]  R. Ness,et al.  Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. , 2005, American journal of obstetrics and gynecology.